Rimegepant Is Now Approved for Migraine Prevention

August 2021

Rimegepant (Nurtec ODT) will now be used for migraine PREVENTION in adults...in addition to acute TREATMENT.

It'll be promoted to help patients "take control of migraine with one medication." But this is misleading.

Rimegepant is dosed as one 75 mg orally disintegrating tablet every OTHER day for prevention...or daily as needed for acute treatment.

Practical advice for a better career, with unlimited access to CE

Hospital Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Compounding Maximize IV Workflow System Benefits
High-Alert Meds Ensure Safety With IV Potassium Chloride
COVID-19 Know the Latest About COVID-19 Monoclonal Antibodies
Communication Be Ready to Help Patients Who Are Deaf or Hard of Hearing
COVID-19 Expect to Dispense Tocilizumab for COVID-19 Under an EUA
Transdermal Patches Ramp Up Transdermal Patch Safety
Alzheimer's Disease Anticipate Debate About Aducanumab for Alzheimer's Disease
Obesity & Weight Loss Avoid Errors With Wegovy During Transitions of Care
Migraine Rimegepant Is Now Approved for Migraine Prevention